The Healthtech Podcast

Dr Owain Rhys Hughes is the founder and CEO of Cinapsis. He has over 13 years of experience working as a doctor and he is a Fellow of the Royal College of Surgeons. He has been awarded a personal Fellowship from the Medical Research Council and has twice received the British Journal of Surgery Prize. Cinapsis SmartReferrals reduces A&E attendances by 83% and face-to-face appointments by 70% through advice & guidance. GPs can contact specialists for advice quickly and securely. Cinapsis SmartReferrals makes it very easy for primary care physicians, nurses, paramedics and pharmacists to talk directly and securely with local specialists. Specialists direct patient flow and improve efficiency by controlling when and where they see patients. Cinapsis SmartReferrals has been designed with consultants to help them work efficiently and without disruption. https://www.linkedin.com/in/owainrhyshughes/ | https://www.cinapsis.org/ Get in touch: www.jamessomauroo.com | www.somx.co.uk

James has read the reports from the McKinsey Global Institute and Octopus Ventures so you don't have to... but they're also linked below. McKinsey's "Prioritizing health: A prescription for prosperity" concludes that by improving health globally, we can save lives and inject trillions into the global economy and they lay out some key findings in the exec summary which gives you the best overview. And Octopus Ventures have pinpointed huge innovation opportunities in fertility treatment, with global investment over the last five-year period topping $2.2bn (rising to $750m last year). Check out the reports here: 1. https://www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/prioritizing-health-a-prescription-for-prosperity 2. https://octopusgroup.com/newsroom/latest-news/octopus-ventures-pinpoints-innovation-opportunities-in-fertility/ Get in touch: www.jamessomauroo.com | www.somx.co.uk

Charles is a scientist with interests at the intersection of physics, machine learning, and computational biology and is the founder of Unlearn.ai . Previously, Charles worked as a machine learning engineer at Leap Motion and a computational biologist at Pfizer. He was a Philippe Meyer Fellow in theoretical physics at École Normale Supérieure in Paris, France, and a postdoctoral scientist in biophysics at Boston University. Charles holds a Ph.D. in biophysics from Harvard University and a B.S. in biophysics from the University of Michigan. Unlearn creates Digital Twins to populate Intelligent Control Arms in clinical studies. While others leverage existing data, Unlearn generates a new type of data, for any type of patient. A Digital Twin is a longitudinal, computationally generated clinical record that describes what would have happened if a specific patient received a placebo. https://www.linkedin.com/in/drckf/ | www.unlearn.ai Get in touch: www.jamessomauroo.com | www.somx.co.uk

This week, James is joined by an old friend and colleague, Dr. Kevin Rafferty. James and Kevin did anaesthetics together and Kevin still practices today. He uses his own VR headset design when anaesthetising his paediatric patients and tells us all about that and his vision for VR right across the patient-journey when it comes to anaesthetics and surgery. https://www.linkedin.com/in/kevin-rafferty-7a1082138/ | https://www.raffertydistractionheadset.com/ Get in touch: www.jamessomauroo.com | www.somx.co.uk

This week, James is joined by Jeremy (Jerry) Biggs, the Founder and Chief Executive Officer at NCL, a specialist investment management firm focusing on high growth technology companies, predominantly in the medical and energy sectors. Jerry has over 15 years of investment and corporate finance experience and sits on the board of a number of high growth businesses. Previously, Jeremy worked for Northern Trust Global Investments, HSBC Investment Bank and BoS Investments and has been the Investment Director for a UK based family office. NCL invest in Seed and Series A rounds where they can deploy their expertise and capital to help  companies achieve an early inflection point in valuation. They consciously choose investments that create an impact on the lives of patients as well as financial return for their investors. Get in touch: www.jamessomauroo.com | www.somx.co.uk

This week James is again joined by Sam Shah to talk about being BAME in healthcare and technology. Sam is a clinical lead with an interest in healthcare technology, digital experience, translational research and supporting behaviour change. He is an NHS Consultant with experience in clinical commissioning, service redesign, public health, workforce planning and health economics. He is also a Digital Health Tech Advisor, the FT's 4th most influential BAME tech leader 2019, a Finalist 2019 Digital Leaders 100 and BIMA 100 #BLM Ideas form: https://js470961.typeform.com/to/OYbQY2lR Sam's Linkedin: https://www.linkedin.com/in/sam-shah-nhs/ | https://twitter.com/healthyopinion Get in touch: www.jamessomauroo.com | www.somx.co.uk

This week, James is joined by Prashant, an expert in the field of Artificial Intelligence and Deep learning. He has architected and commercialized several data science solutions in his 15 year career. He is also a prolific researcher, author, and speaker on topics related to data science and machine learning. He is passionate about using deep learning to make healthcare affordable and accessible. Qure.ai uses deep learning to diagnose disease from CT Scans, X-Rays and MRIs and create automated diagnostic reports. This will help radiologists make faster and more accurate decisions in the developed countries and provide automated radiology support to physicians in rural areas, where radiologists are typically not available. Get in touch: www.jamessomauroo.com | www.somx.co.uk

In this week's Sunday session, James talks about the latest in VR in healthcare and you can read the Forbes article below. Forbes article on VR in healthcare: https://www.forbes.com/sites/jamessomauroo/2020/06/19/virtual-reality-helps-medics-beat-coronavirus/ James' upcoming podcast talk: https://www.eventbrite.co.uk/e/lunch-learn-how-can-podcasting-benefit-your-healthtech-startup-tickets-109608102786 HSC Ventures: https://hscventures.co.uk/ Get in touch: www.jamessomauroo.com | www.somx.co.uk

This week, James is joined by Chris Caulfield, a registered nurse and cofounder / chief nursing officer at Intelycare. After witnessing short staffing as a floor nurse and union leader, Chris built a solution to reduce nurse staffing shortages by joining forces with a full-stack engineer and developed an on-demand, app-based scheduling solution for nurses and nursing facilities. Chris filled IntelyCare's first shift four years ago, and since then, he's been helping the organisation grow across the US. Today, IntelyCare has over 11,000 active Nursing professionals who've filled over two and a half million hours of skilled nursing care, making IntelyCare the fastest growing healthcare staffing company in the US. Forbes article: https://www.forbes.com/sites/jamessomauroo/2020/03/02/healthtech-startup-receives-45million-in-biggest-ever-nursing-investment/ https://www.intelycare.com/ | https://www.linkedin.com/in/christophercaulfield/ Get in touch: www.jamessomauroo.com | www.somx.co.uk

This week's Sunday Session is a summary of James' latest Forbes article covering the recent $16M acquisition of Zesty by Induction Healthcare Group. There's also the final thoughts from Sam Shah from the last episode on BAME, healthcare and technology to help all those who want to be part of the solution when it comes to eliminating discrimination in healthtech. Read the Forbes article here: https://www.forbes.com/sites/jamessomauroo/2020/06/12/16m-healthtech-acquisition-signals-shift-in-clinician-patient-communication/ Get in touch: www.jamessomauroo.com | www.somx.co.uk